Detalhe da pesquisa
1.
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Histopathology
; 84(7): 1224-1237, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422618
2.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
3.
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Oncologist
; 28(1): e26-e35, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342081
4.
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma.
Mod Pathol
; 35(11): 1618-1623, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970994
5.
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
Oncologist
; 26(1): e153-e163, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918774
6.
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Oncologist
; 26(7): e1263-e1272, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904632
7.
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases.
Mod Pathol
; 34(2): 252-263, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32884129
8.
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
Oncologist
; 25(11): 943-953, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869930
9.
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Mod Pathol
; 33(11): 2307-2317, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461620
10.
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Gynecol Oncol
; 157(2): 357-366, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156473
11.
Genomic Landscape of Adult and Pediatric BCR-ABL1-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing.
Oncologist
; 24(3): 372-374, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181314
12.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist
; 24(2): 219-228, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108156
13.
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.
Mod Pathol
; 32(11): 1675-1687, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31190001
14.
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
J Urol
; 201(3): 541-548, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291913
15.
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Cancer
; 124(7): 1358-1373, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29338072
16.
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
Oncologist
; 23(7): 776-781, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540602
17.
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Blood
; 127(24): 3004-14, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26966091
18.
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Oncologist
; 22(7): 834-842, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495808
19.
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.
Oncologist
; 22(12): 1444-1450, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079636
20.
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Oncologist
; 22(12): 1478-1490, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28912153